Metrovacesa revenue and financials
€10.46Change from previous close: +0.58%Absolute change: +€0.06
In the fiscal year ended December 2025, Metrovacesa reported revenue of €708.46M (+8.37% year over year). Net income was €56.86M, a net margin of 8.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +8.37%
- 2025 vs 2024
- Net income growth
- +257.94%
- 2025 vs 2024
- Net margin
- 8.0%
- 2024: 2.4%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q4 2025 | Q2 2025 |
|---|---|---|
| Total assets | 2,258 | 2,417 |
| Current assets | 1,874 | 2,028 |
| Cash and equivalents | 130 | 32.8 |
| Short-term investments | 7.5 | 27.7 |
| Inventory | 1,557 | 1,822 |
| Net property, plant and equipment | 3.1 | 3.5 |
| Long-term investments | 49.5 | 49.1 |
| Current liabilities | 521 | 607 |
| Accounts payable | 71.3 | 95.8 |
| Long-term debt | 254 | 232 |
| Total debt | 404 | 435 |
| Total liabilities | 844 | 905 |
| Total equity (incl. minority) | 1,414 | 1,512 |
| Retained earnings | -205 | -277 |